CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 129 filers reported holding CHEMOCENTRYX INC in Q4 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $160,000 | +16.8% | 23,600 | +59.5% | 0.02% | +122.2% |
Q2 2019 | $137,000 | -94.7% | 14,794 | -92.0% | 0.01% | -92.4% |
Q1 2019 | $2,562,000 | +86.2% | 184,500 | +46.2% | 0.12% | +25.3% |
Q4 2018 | $1,376,000 | -20.2% | 126,200 | -7.5% | 0.10% | -4.0% |
Q3 2018 | $1,724,000 | -20.1% | 136,400 | -16.8% | 0.10% | -21.4% |
Q2 2018 | $2,158,000 | +153.6% | 163,900 | +161.8% | 0.13% | +133.3% |
Q1 2018 | $851,000 | -1.4% | 62,600 | -56.9% | 0.05% | +17.4% |
Q4 2017 | $863,000 | -30.1% | 145,100 | -12.9% | 0.05% | -30.3% |
Q3 2017 | $1,235,000 | +4.7% | 166,500 | +32.0% | 0.07% | -9.6% |
Q2 2017 | $1,180,000 | +12.4% | 126,100 | -12.6% | 0.07% | +10.6% |
Q1 2017 | $1,050,000 | +43.1% | 144,300 | +18.7% | 0.07% | +11.9% |
Q3 2016 | $734,000 | +138.3% | 121,600 | -1.9% | 0.06% | +90.3% |
Q1 2016 | $308,000 | +14.9% | 123,900 | +247.1% | 0.03% | -16.2% |
Q1 2015 | $268,000 | – | 35,700 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |